Targeted Oncology13h
FDA Accepts NDA Resubmission of Rivoceranib and Camrelizumab in HCC
The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic ...
Experimental ALS drug could offer new hope for patients if approved, researchers say
New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking ...
News Medical20h
How to navigate chemistry, manufacturing, and controls (CMC ) challenges in breakthrough drug development
Learn how to effectively navigate the challenges of CMC in breakthrough drug development. Discover key strategies here.
Monthly Prescribing Reference5h
Aceclidine-Based Eye Drop Under Review for Presbyopia
LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.
Zacks.com on MSN3d
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz
Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking ...
GlobalData on MSN3d
Intercept’s liver disease drug Ocaliva faces FDA approval delay
An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...
How Quantum Computing Is Accelerating Drug Discovery And Development
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with ...
Ozempic may help battle drug and alcohol addiction
Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according ...
Medscape4d
FDA OKs Once-Nightly Lumryz for Children with Narcolepsy
Lumryz is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in children ...
AI Simulations Help Drug Trials
AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...